FindTrial
Sign In

Effectiveness of Antenatal Dexamethasone on Respiratory Complications in Late Preterm Infants

Effectiveness of Antenatal Dexamethasone on Respiratory Complications in Late Preterm Infants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20161112002
Enrollment
Unknown
Registered
2016-11-12
Start date
2016-11-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late preterm birth with respiratory complication.

Interventions

Dexamethasone 6mg IM q 12 hr.,Sterile water for injection 1.5 ml IM q 12 hr.
Experimental Drug,Placebo Comparator No treatment
Dexamethasone group,Placebo group

Sponsors

no
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Single pregnant woman with certain gestational age between 34-36+6 week. 2. Preterm labor. 3. No intrauterine growth restriction.

Exclusion criteria

Exclusion criteria: 1. Previously recieve glucocorticoid 2. Cervical dilatation morethan 8 cm. 3. Fetal abnormality and congenital anormally. 4. Labor after GA 37 wk. 5. Pregnant woman with uncontrolled infection. 6. deny to join in the study.

Design outcomes

Primary

MeasureTime frame
Respiratory complications date of dischart Number of case—

Secondary

MeasureTime frame
no no no—

Countries

Thailand

Contacts

Public ContactAdisak Waiketkarn

no

awaiketkarn@gmail.com0639397788

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026